An overview of acute gastrointestinal side effects of systemic anti-cancer therapy and their management
P Smith, A Lavery, RC Turkington - Best Practice & Research Clinical …, 2020 - Elsevier
Abstract Treatment-related acute gastrointestinal toxicities are a common and often
debilitating hurdle encountered in the treatment of cancer patients. While the introduction of …
debilitating hurdle encountered in the treatment of cancer patients. While the introduction of …
Cannabinoids in patients with nausea and vomiting associated with malignancy and its treatments
JM Garcia, TA Shamliyan - The American Journal of Medicine, 2018 - amjmed.com
Cannabis-based medications (cannabinoids) have been approved by the US Food and
Drug Administration (FDA) for the treatment of adults with chemotherapy-induced nausea. 1 …
Drug Administration (FDA) for the treatment of adults with chemotherapy-induced nausea. 1 …
Palonosetron for prevention of delayed chemotherapy-induced nausea and vomiting in pediatric patients: a meta-analysis
A Yamaguchi, Y Saito, Y Takekuma… - Supportive Care in …, 2024 - Springer
Purpose Chemotherapy-induced nausea and vomiting (CINV) are common adverse events
in patients undergoing emetogenic chemotherapy. Palonosetron, a second-generation 5 …
in patients undergoing emetogenic chemotherapy. Palonosetron, a second-generation 5 …
Comparison of olanzapine 2.5 mg and 5 mg in the prevention of chemotherapy-induced nausea and vomiting: a Japanese nationwide database study
H Suzuki-Chiba, T Konishi, S Aso, K Makito… - International Journal of …, 2024 - Springer
Background Olanzapine is prescribed as prophylaxis for chemotherapy-induced nausea
and vomiting at a dose of 2.5 or 5 mg in Asian countries. We compared the effectiveness of …
and vomiting at a dose of 2.5 or 5 mg in Asian countries. We compared the effectiveness of …
[HTML][HTML] Сопроводительная терапия при множественной миеломе: практические рекомендации
МВ Соловьев, МВ Соловьева… - Клиническая …, 2023 - cyberleninka.ru
Сопроводительная терапия приобретает все более важную роль в современном
алгоритме лечения множественной миеломы (ММ). Внедрение в клиническую практику …
алгоритме лечения множественной миеломы (ММ). Внедрение в клиническую практику …
Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy
Background The role of olanzapine in the treatment of chemotherapy-induced nausea and
vomiting (CINV) in addition to the antiemetic therapeutic combination with aprepitant …
vomiting (CINV) in addition to the antiemetic therapeutic combination with aprepitant …
Application of evidence-based non-pharmacological interventions on chemotherapy induced nausea and vomiting among gynecologic patients with tumor.
Z Huaiqing, W Huansheng, Z Peihai… - Chinese Nursing …, 2023 - search.ebscohost.com
Objective: To construct non-pharmacological interventions of chemotherapy induced nausea
and vomiting (CINV) among gynecologic patients with tumor based on evidence-based …
and vomiting (CINV) among gynecologic patients with tumor based on evidence-based …
Marketing Analysis: Antiemetic Drugs on the Pharmaceutical Market of Uzbekistan
YK Mannanovna - 2021 - researchsquare.com
In this study, we analysed, with the help of the “State Register of Medicines, Medical Devices
and Medical Equipment Permitted for Use in Medical Practice of the Republic of …
and Medical Equipment Permitted for Use in Medical Practice of the Republic of …